Talk:New Article Requests
Before You Submit a Proposal
- EVALUATION CRITERIA: Review these to be sure your proposal is eligible.
- EXISTING ARTICLES: Review these to see if your proposed topic is already included or could be inlcuded in an existing EyeWiki article. You can do this by performing a thorough search using various related key terms.
- If you find a pre-existing stand-alone article that addresses your topic or an article that includes your topic please edit the article to include your own input. You will be automatically recognized as a contributor to that article.
- Of those proposals that are not accepted, 85% are rejected because the topic is already covered or could be covered in an existing EyeWiki article.
- PROPOSALS PREVIOUSLY SUBMITTED: Review these and please do not resubmit these topics.
Instructions
- IMPORTANT: Review the section above "Before You Submit a Proposal"
- Click the "Add topic" link to create a new proposal on this page
- Then add the relevant list items as shown
- Title: Enter this in the Subject field
- Summary: Please provide some details about what will be covered and why you think the article would benefit EyeWiki. Do not submit a complete article.
- Section: Indicate what subspecialty section the article should be added to. You may indicate up to 2 sections.
- Submitted by: Name of the ophthalmologist submitting the proposal. Sign and date your request by entering 4 tilde ~ characters only. This will automatically add your username, a time stamp and a link to your profile. You will see this after you save the page.
- SAMPLE: Rayna.Ungersma.AAO (talk) 10:01, April 30, 2024 (PDT)
- Click: SAVE at the bottom of the page
Sample Proposal
Biosimilars in Ophthalmology
Summary: Patents for original biologics used to treat nAMD and DME are approaching expiration. Numerous companies are striving to replicate these biologics as biosimilars, which are drugs that mimic the effects of the original biologic, but do not have the same active ingredients. This article will summarize the current literature about biosimilars and their safety, efficacy, and quality and provide an in-depth review of approved biosimilars as well as those that are in development. This article will provide EyeWiki readers with information about numerous alternatives for treatment nAMD and DME.
Section: Retina/Vitreous
Submitted by: Rayna.Ungersma.AAO (talk) 15:04, May 1, 2024 (PDT)
Retinal Vascular Tortuosity
Summary: Retinal vascular tortuosity is characterized by the abnormal twisting, turning, or coiling of the retinal blood vessels, which can involve the arteries, veins, or both. This clinical sign, observable through fundoscopic examination, can manifest in the central retina, the peripheral areas, or both. It may be congenital or acquired and is often associated with a variety of systemic and ocular conditions. This article aims to provide a comprehensive overview of the etiology and differential diagnosis of retinal vascular tortuosity. It will serve as a reference resource in understanding the causes associated with this clinical sign. Section: Retina/Vitreous Submitted by: --Ahmed.F.Shakarchi (talk) 09:13, September 14, 2024 (PDT)
Neuro-Ophthalmic Manifestations of Chordoma
Summary: Chordoma is a rare, slow-growing, yet locally invasive and aggressive tumor that is derived from notochordal remnants. Chordomas have a propensity to develop in the midline axial skeleton, including the skull base, spine, and sacrum. They are highly recurrent, have poor prognoses, and typically present late with non-specific symptoms and a large tumor burden, contributing to delayed diagnoses. Skull-base chordomas may present with neuro-ophthalmic manifestations, including headache, diplopia, palsy of cranial nerve VI, most commonly, as well as that of III and IV, and occasionally visual field defects. Clinicians should be aware of the possible neuro-ophthalmic manifestations of chordoma, which this article aims to review. This article will serve as a resource for understanding the presenting ocular signs and symptoms that are associated with chordoma as well as the epidemiology, etiology, pathophysiology, risk factors, tools for diagnosis, ocular findings, and management of chordoma. Section: Neuro-ophthalmology/Orbit Submitted by: Sanjana.Jaiswal (talk) 06:26, September 19, 2024 (PDT)
Summary: Amyloidosis encompasses a group of disorders characterized by the pathological accumulation of insoluble, misfolded proteins in the extracellular space. Among these, transthyretin-related amyloidosis (ATTR) specifically involves the deposition of mutated transthyretin (TTR) protein. This severe systemic disease primarily affects the heart, peripheral nervous system, kidneys, and eyes. TTR plays a crucial role in the transport of retinol (vitamin A) and thyroxine (T4), making its proper functioning essential for various physiological processes. Recent therapeutic advancements include small interfering RNA (siRNA) drugs designed to inhibit TTR production, effectively reducing amyloid accumulation. However, this intervention may also disrupt TTR's role in retinol transport, increasing the risk of vitamin A deficiency. This article aims to outline necessary precautions and identify at-risk patients when prescribing these therapies, ensuring effective management and prevention of debilitating vitamin A deficiency. Section: Retina/Vitreous Submitted by: Sanjana.Jaiswal (talk) 06:30, September 19, 2024 (PDT)
